Royal Bank of Canada’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-200
| Closed | -$1K | – | 7609 |
|
|
2025
Q4 | $1K | Hold |
200
| – | – | ﹤0.01% | 7039 |
|
|
2025
Q3 | $0 | Sell |
200
-80
| -29% | -$128 | ﹤0.01% | 7470 |
|
|
2025
Q2 | $0 | Sell |
280
-2,115
| -88% | -$2.76K | ﹤0.01% | 7303 |
|
|
2025
Q1 | $2K | Buy |
2,395
+2,120
| +771% | +$2.56K | ﹤0.01% | 6585 |
|
|
2024
Q4 | $0 | Hold |
275
| – | – | ﹤0.01% | 7200 |
|
|
2024
Q3 | $1K | Sell |
275
-2,156
| -89% | -$7.1K | ﹤0.01% | 6740 |
|
|
2024
Q2 | $8K | Buy |
2,431
+2,146
| +753% | +$7.65K | ﹤0.01% | 6424 |
|
|
2024
Q1 | $1K | Sell |
285
-744
| -72% | -$4.77K | ﹤0.01% | 6850 |
|
|
2023
Q4 | $8K | Sell |
1,029
-371
| -27% | -$2.08K | ﹤0.01% | 6565 |
|
|
2023
Q3 | $17K | Sell |
1,400
-693
| -33% | -$7.15K | ﹤0.01% | 6240 |
|
|
2023
Q2 | $22K | Buy |
2,093
+1,460
| +231% | +$15K | ﹤0.01% | 6172 |
|
|
2023
Q1 | $6K | Sell |
633
-49
| -7% | -$562 | ﹤0.01% | 6518 |
|
|
2022
Q4 | $10K | Buy |
682
+57
| +9% | +$853 | ﹤0.01% | 6552 |
|
|
2022
Q3 | $8K | Hold |
625
| – | – | ﹤0.01% | 6548 |
|
|
2022
Q2 | $9K | Hold |
625
| – | – | ﹤0.01% | 6431 |
|
|
2022
Q1 | $9K | Sell |
625
-278
| -31% | -$4.12K | ﹤0.01% | 7008 |
|
|
2021
Q4 | $20K | Sell |
903
-425
| -32% | -$10K | ﹤0.01% | 6810 |
|
|
2021
Q3 | $35K | Buy |
1,328
+60
| +5% | +$1.94K | ﹤0.01% | 6369 |
|
|
2021
Q2 | $40K | Sell |
1,268
-88
| -6% | -$2.88K | ﹤0.01% | 6186 |
|
|
2021
Q1 | $41K | Buy |
1,356
+627
| +86% | +$21.3K | ﹤0.01% | 6012 |
|
|
2020
Q4 | $25K | Buy |
729
+529
| +265% | +$15.8K | ﹤0.01% | 5964 |
|
|
2020
Q3 | $6K | Buy |
200
+100
| +100% | +$2.65K | ﹤0.01% | 6096 |
|
|
2020
Q2 | $3K | Buy |
+100
| New | +$3.21K | ﹤0.01% | 6207 |
|
Royal Bank of Canada's RPTX Position: Q1 2026 in Review
Royal Bank of Canada sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 200 shares — an estimated $1K sold.
Royal Bank of Canada first reported a position in RPTX in Q2 2020 and held it in 23 quarters. The position peaked at $41K in Q1 2021. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.
- Royal Bank of Canada reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
- Royal Bank of Canada sold 200 Repare Therapeutics shares in Q1 2026, an estimated $1K.
- Royal Bank of Canada first reported a position in Repare Therapeutics in Q2 2020 and held it in 23 quarters.
- Royal Bank of Canada's Repare Therapeutics position peaked at $41K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.